Hilltop Park Associates’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | $315K | Buy |
12,500
+3,125
| +33% | +$78.8K | 0.58% | 20 |
|
|
2016
Q2 | $232K | Buy |
9,375
+1,250
| +15% | +$30.9K | 0.97% | 7 |
|
|
2016
Q1 | $235K | Sell |
8,125
-10,625
| -57% | -$307K | 0.52% | 17 |
|
|
2015
Q4 | $696K | Buy |
18,750
+4,062
| +28% | +$151K | 2.32% | 12 |
|
|
2015
Q3 | $716K | Sell |
14,688
-312
| -2% | -$15.2K | 10.78% | 1 |
|
|
2015
Q2 | $1.03M | Sell |
15,000
-2,013
| -12% | -$139K | 2.05% | 16 |
|
|
2015
Q1 | $608K | Buy |
+17,013
| New | +$608K | 1.11% | 20 |
|